Scholar Rock Holding (SRRK) Accumulated Depreciation (2017 - 2025)

Scholar Rock Holding's (SRRK) quarterly Accumulated Depreciation came in at $14.9 million in Q4 2025, up 12.54% year-on-year from $13.2 million in Q4 2024, and up 12.54% quarter-over-quarter from $13.2 million in Q4 2024.

Scholar Rock Holding (SRRK) Accumulated Depreciation (2017 - 2025) Analysis & Trends

Scholar Rock Holding's Accumulated Depreciation history runs 9 years deep, the most recent figure standing at $14.9 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation rose 12.54% year-over-year to $14.9 million in Q4 2025; TTM through Dec 2025 was $14.9 million, a 12.54% increase from a year earlier, with the FY2025 full-year figure at $14.9 million, up 12.54% from the prior year.
  • Accumulated Depreciation advanced to $14.9 million in Q4 2025 per SRRK's latest filing, from $13.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation topped out at $14.9 million in Q4 2025 and bottomed at $7.3 million in Q4 2021.
  • The 5-year median for Accumulated Depreciation is $11.3 million (2023), against an average of $11.4 million.
  • Across the five-year window, Accumulated Depreciation surged 50.05% in 2021 and climbed 10.7% in 2023, its largest moves.
  • Year by year, Accumulated Depreciation stood at $7.3 million in 2021, then surged by 40.32% to $10.2 million in 2022, then increased by 10.7% to $11.3 million in 2023, then climbed by 16.7% to $13.2 million in 2024, then advanced by 12.54% to $14.9 million in 2025.
  • Per Business Quant, the three latest SRRK Accumulated Depreciation figures stand at $14.9 million (Q4 2025), $13.2 million (Q4 2024), and $11.3 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Scholar Rock Holding 6.30 Bn 6.30 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 14.88 Mn
Dec 31, 2024 13.22 Mn
Dec 31, 2023 11.33 Mn
Dec 31, 2022 10.23 Mn
Dec 31, 2021 7.29 Mn
Dec 31, 2020 4.86 Mn
Dec 31, 2019 3.56 Mn
Dec 31, 2018 2.36 Mn
Sep 30, 2018 2.12 Mn
Jun 30, 2018 1.91 Mn
Dec 31, 2017 1.55 Mn